ArticleCancer science2023

TAS2940, a novel brain-penetrable pan-ERBB inhibitor, for tumors with HER2 and EGFR aberrations.

Kei Oguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.